Brian Wainger, MD, PhD: Future Studies Evaluating Motor Neuron Excitability in ALS
The assistant professor of neurology and anesthesiology at Harvard Medical School detailed the future outlook of ezogabine and whether it may be studied again in patients with ALS.
AUPN Leadership Minute Episode 5: Planning a Faculty Retreat
Episode 5 of the AUPN Leadership Minute features Alissa Willis, MD, of University of Mississippi Medical Center; and Steven Vernino, MD, PhD, of UT Southwestern Medical Center. [WATCH TIME: 4 minutes]
Raymond Sanchez, MD: Phase 3 TEMPO Trials Guide Tavapadon
The chief medical officer of Cerevel Therapeutics detailed the TEMPO trials, a trio of studies that will examine tavapadon in patients with early and late-stage Parkinson disease.
Pavel Klein, MD: Finding the Right AEDs for Patients With Epilepsy
The director of the Mid-Atlantic Epilepsy and Sleep Center urged physicians to catch refractory epilepsy early and look for the most efficacious treatments for their patients.
FDA Approves EEG System, Neurologic Diagnostic Out-Of-Pocket Costs Rising, Nerivio Safe for Adolescents With Migraine
Neurology News Network for the week ending January 9, 2021.
Future Outlook for Dravet Syndrome
Choosing Cannabidiol or Fenfluramine for Dravet
Approval of Cannabidiol and Fenfluramine for Dravet
Treatment Options for Dravet Syndrome
Importance of Early Diagnosis of Dravet Syndrome
Overview of Dravet Syndrome
William Rosenfeld, MD: Decreasing Concomitant ASM Use With Cenobamate for Epilepsy
The neurologist from the Comprehensive Epilepsy Care Center for Children and Adults, in St. Louis, Missouri, discussed how his team saw a roughly 25% decrease in the mean use of concomitant ASMs.
Richard B. Lipton, MD: Challenges of Treating Migraine
The director of the Montefiore Headache Center discussed how different treatments work for different patients with migraine.
Todd Levine, MD: Synuclein’s Role in Parkinson Disease Diagnosis
The chief medical officer of CND Life Sciences and medical director of Honor Health Neurology spoke to the role synuclein has played in advancing PD diagnosis.
Michael Okun, MD: Importance of Disease-Based Registries
The executive director of the Norman Fixel Institute for Neurological Diseases explained how disease-based registries play a crucial part in changing the approval system for neurologic devices in rare diseases.
TRIUMPHANT-MS Trial: Fatigue in MS
Brian Wainger, MD, PhD: Motor Neuron Excitability in ALS
The assistant professor of neurology and anesthesiology at Harvard Medical School provided context on the potential of motor neuron excitability in patients with ALS.
Multiple Sclerosis Fatigue
Merit Cudkowicz, MD, MSc: Assessing NurOwn in ALS
The director of the Healey & AMG Center for ALS spoke to the recent topline results of a phase 3 study of NurOwn in patients with the neuromuscular disease.
Pavel Klein, MD: Brivaracetam Efficacy Inversely Proportional to Number of Lifetime AEDs
The director of the Mid-Atlantic Epilepsy and Sleep Center urged physicians to try and find the right medications for their patients as early as possible.
Larger Infarct Volume Associated With Poorer Outcomes, Edavarone Shows Efficacy in ALS, DMD Treatment Demonstrates Proof-Of-Concept
Neurology News Network for the week ending January 2, 2021.
QoL Issues in the Management of Multiple Sclerosis
William Rosenfeld, MD: Finding Ideal Combinations of Cenobamate and Concurrent ASMs
The neurologist from the Comprehensive Epilepsy Care Center for Children and Adults, in St. Louis, Missouri, discussed how his team succeeded at titrating cenobamate early in the study.
Challenges in Optimally Treating Multiple Sclerosis
Pavel Klein, MD: Efficacy of Brivaracetam on Refractory Epilepsy
The director of the Mid-Atlantic Epilepsy and Sleep Center urged physicians to actively look for new medications for patients to try.
Jude Savarraj, PhD: Applying Machine Learning to Healthcare
The research scientist from the University of Texas Medical School discussed some of the challenges and opportunities that machine learning presents in patient care.
William Rosenfeld, MD: Balancing Cenobamate and Concomitant ASMs
The neurologist from the Comprehensive Epilepsy Care Center for Children and Adults, in St. Louis, Missouri, discussed how his team studied the interactions of ASMs and cenobamate.
Cerebrospinal Fluid in Diagnosing Multiple Sclerosis
Pavel Klein, MD: Challenges of Treating Drug-Resistant Epilepsy
The director of the Mid-Atlantic Epilepsy and Sleep Center also noted how serious adverse effects from treatment can be detrimental to patients’ lives.
Jude Savarraj, PhD: Applying Machine Learning to Predict Outcomes
The research scientist from the University of Texas Medical School discussed how he would like to use machine learning to aid in prediction and prophylactic treatment.
